Delivery Order SPE2DB22D1017-SPE2DB25FG1MR
Award Date
4/30/25
Potential Completion Date
5/21/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Zeposia 0.92 mg capsules, a medication used to treat certain medical conditions. The contract has a firm fixed price of $13,862.79 and a completion date of July 22, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Zeposia 0.92 mg capsules. The contract has a firm fixed price of $13,862.79 and a performance period ending on July 30, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $4,466.57 firm-fixed-price contract is for the supply of the prescription medication Zeposia 0.92 MG Capsule 30S. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPOSIA 0.92 MG CAPSULE 30S, a prescription medication, with a ceiling value of $27,725.58 and a period of performance through July 21, 2025. The contract is not designated as a set-aside and appears to be open competition. AmerisourceBergen Drug Corp holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a prescription medication, with a ceiling value of $13,862.79 and a performance period ending on August 5, 2025. The contract is not set-aside and represents an open competition. AmerisourceBergen Drug Corporation holds a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The award is for the delivery of the pharmaceutical product Zeposia 0.92 MG Capsule 30S, with a ceiling value of $13,399.71 and a period of performance through April 26, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. This IDC serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $26,799.42 delivery order is for the medication Zeposia 0.92 MG Capsule 30S and has a completion date of May 14, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to military healthcare...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Zeposia 0.92 mg capsules in 30-count packages, with a ceiling value of $4,620.93 and a final completion date of July 25, 2025. The contract is a firm-fixed-price type and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for Zeposia 0.92 MG Capsule 30S, a pharmaceutical product, with a potential value of $8,933.14 and a completion date of February 16, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. The award has a ceiling value of $13,862.79 and a final completion date of July 17, 2025. This delivery order is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...